• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

晚期癌症患者顽固性呼吸困难的病因及管理:药物治疗的系统评价

The etiology and management of intractable breathlessness in patients with advanced cancer: a systematic review of pharmacological therapy.

作者信息

Booth Sara, Moosavi Shakeeb H, Higginson Irene J

机构信息

Cambridge University NHS Foundation Trust Hospital, UK.

出版信息

Nat Clin Pract Oncol. 2008 Feb;5(2):90-100. doi: 10.1038/ncponc1034.

DOI:10.1038/ncponc1034
PMID:18235441
Abstract

Intractable breathlessness is a common, devastating symptom of advanced cancer causing distress and isolation for patients and families. In advanced cancer, breathlessness is complex and usually multifactorial and its severity unrelated to measurable pulmonary function or disease status. Therapeutic advances in the clinical management of dyspnea are limited and it remains difficult to treat successfully. There is growing interest in the palliation of breathlessness, and recent work has shown that a systematic, evidence-based approach by a committed multidisciplinary team can improve lives considerably. Where such care is lacking it may be owing to therapeutic nihilism in clinicians untrained in the management of chronic breathlessness and unaware that there are options other than endurance. Optimum management involves pharmacological treatment (principally opioids, occasionally oxygen and anxiolytics) and nonpharmacological interventions (including use of a fan, a tailor-made exercise program, and psychoeducational support for patient and family) with the use of parenteral opioids and sedation at the end of life when appropriate. Effective care centers on the patient's needs and goals. Priorities in breathlessness research include studies on: neuroimaging, the effectiveness of new interventions, the efficacy, safety, and dosing regimens of opioids, the contribution of deconditioning, and the effect of preventing or reversing breathlessness.

摘要

难治性呼吸困难是晚期癌症常见的、极具破坏性的症状,给患者及其家人带来痛苦和孤立感。在晚期癌症中,呼吸困难情况复杂,通常是多因素导致的,其严重程度与可测量的肺功能或疾病状态无关。呼吸困难临床管理方面的治疗进展有限,成功治疗仍然困难。人们对缓解呼吸困难的关注度日益增加,最近的研究表明,由一个坚定的多学科团队采用系统的、基于证据的方法可以显著改善患者生活。如果缺乏这种护理,可能是由于临床医生对慢性呼吸困难管理缺乏培训,存在治疗虚无主义,并且没有意识到除了忍耐之外还有其他选择。最佳管理包括药物治疗(主要是阿片类药物,偶尔使用氧气和抗焦虑药)和非药物干预(包括使用风扇、量身定制的运动计划以及为患者及其家人提供心理教育支持),在生命末期酌情使用胃肠外阿片类药物和镇静剂。有效的护理以患者的需求和目标为中心。呼吸困难研究的重点包括:神经影像学、新干预措施的有效性、阿片类药物的疗效、安全性和给药方案、失健状态的影响以及预防或逆转呼吸困难的效果。

相似文献

1
The etiology and management of intractable breathlessness in patients with advanced cancer: a systematic review of pharmacological therapy.晚期癌症患者顽固性呼吸困难的病因及管理:药物治疗的系统评价
Nat Clin Pract Oncol. 2008 Feb;5(2):90-100. doi: 10.1038/ncponc1034.
2
Interventions for palliative symptom control in COVID-19 patients.干预措施以控制 COVID-19 患者的姑息症状。
Cochrane Database Syst Rev. 2021 Aug 23;8(8):CD015061. doi: 10.1002/14651858.CD015061.
3
Telehealth interventions: remote monitoring and consultations for people with chronic obstructive pulmonary disease (COPD).远程医疗干预:针对慢性阻塞性肺疾病(COPD)患者的远程监测和咨询。
Cochrane Database Syst Rev. 2021 Jul 20;7(7):CD013196. doi: 10.1002/14651858.CD013196.pub2.
4
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
5
Non-pharmacological interventions for breathlessness in advanced stages of malignant and non-malignant diseases.恶性和非恶性疾病晚期呼吸困难的非药物干预措施。
Cochrane Database Syst Rev. 2008 Apr 16(2):CD005623. doi: 10.1002/14651858.CD005623.pub2.
6
WITHDRAWN: Interventions for fatigue and weight loss in adults with advanced progressive illness.撤回:针对晚期进行性疾病成人患者疲劳和体重减轻的干预措施。
Cochrane Database Syst Rev. 2017 Apr 7;4(4):CD008427. doi: 10.1002/14651858.CD008427.pub3.
7
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
8
The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.卡莫司汀植入剂与替莫唑胺治疗新诊断的高级别胶质瘤的有效性和成本效益:一项系统评价与经济学评估
Health Technol Assess. 2007 Nov;11(45):iii-iv, ix-221. doi: 10.3310/hta11450.
9
EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update.欧洲癌症研究与治疗组织(EORTC)癌症贫血患者促红细胞生成蛋白使用指南:2006年更新版
Eur J Cancer. 2007 Jan;43(2):258-70. doi: 10.1016/j.ejca.2006.10.014. Epub 2006 Dec 19.
10
Early palliative care for adults with advanced cancer.晚期癌症成年患者的早期姑息治疗。
Cochrane Database Syst Rev. 2017 Jun 12;6(6):CD011129. doi: 10.1002/14651858.CD011129.pub2.

引用本文的文献

1
Systematic review of the literature on the occurrence and characteristics of dyspnea in oncology patients.肿瘤患者呼吸困难发生情况及特征的文献系统综述
Crit Rev Oncol Hematol. 2023 Jan;181:103870. doi: 10.1016/j.critrevonc.2022.103870. Epub 2022 Nov 12.
2
A Randomized Controlled Trial of a Non-pharmacological Intervention for Cancer-Related Dyspnea.一项针对癌症相关呼吸困难的非药物干预随机对照试验。
Front Oncol. 2020 Dec 1;10:591610. doi: 10.3389/fonc.2020.591610. eCollection 2020.
3
'Scared to death' dyspnoea from the hospitalised patient's perspective.
从住院患者的角度来看,“怕死”的呼吸困难。
BMJ Open Respir Res. 2020 Mar;7(1). doi: 10.1136/bmjresp-2019-000493.
4
Palliative Care and the Management of Common Distressing Symptoms in Advanced Cancer: Pain, Breathlessness, Nausea and Vomiting, and Fatigue.姑息治疗与晚期癌症常见痛苦症状的管理:疼痛、呼吸困难、恶心和呕吐以及疲劳。
J Clin Oncol. 2020 Mar 20;38(9):905-914. doi: 10.1200/JCO.19.00470. Epub 2020 Feb 5.
5
Systemic corticosteroids for the management of cancer-related breathlessness (dyspnoea) in adults.全身用皮质类固醇治疗成人癌症相关性呼吸困难(气短)
Cochrane Database Syst Rev. 2019 Feb 20;2(2):CD012704. doi: 10.1002/14651858.CD012704.pub2.
6
Effects of Oral Morphine on Dyspnea in Patients with Cancer: Response Rate, Predictive Factors, and Clinically Meaningful Change (CJLSG1101).口服吗啡对癌症患者呼吸困难的影响:反应率、预测因素和有临床意义的变化(CJLSG1101)。
Oncologist. 2019 Jul;24(7):e583-e589. doi: 10.1634/theoncologist.2018-0468. Epub 2019 Jan 18.
7
Breathlessness services as a new model of support for patients with respiratory disease.呼吸困难服务为呼吸疾病患者提供了一种新的支持模式。
Chron Respir Dis. 2018 Feb;15(1):48-59. doi: 10.1177/1479972317721557. Epub 2017 Jul 18.
8
Six key topics informal carers of patients with breathlessness in advanced disease want to learn about and why: MRC phase I study to inform an educational intervention.晚期疾病呼吸困难患者的非正式照料者想要了解的六个关键主题及原因:一项为教育干预提供信息的医学研究委员会一期研究
PLoS One. 2017 May 5;12(5):e0177081. doi: 10.1371/journal.pone.0177081. eCollection 2017.
9
Benzodiazepines for the relief of breathlessness in advanced malignant and non-malignant diseases in adults.苯二氮䓬类药物用于缓解成人晚期恶性和非恶性疾病中的呼吸困难。
Cochrane Database Syst Rev. 2016 Oct 20;10(10):CD007354. doi: 10.1002/14651858.CD007354.pub3.
10
A randomised, double-blind controlled trial of intranasal midazolam for the palliation of dyspnoea in patients with life-limiting disease.一项关于鼻内咪达唑仑用于缓解终末期疾病患者呼吸困难的随机双盲对照试验。
Support Care Cancer. 2016 Jul;24(7):3069-76. doi: 10.1007/s00520-016-3125-2. Epub 2016 Feb 18.